RISPERDAL CONSTA bør anvendes med forsigtighed af patienter med risikofaktorer for at få apopleksi.
It was considered shown that it is not mandatory for patients to have been stabilised on oral medications, and even preferable that patients be switched to the long-acting injectable Risperdal Consta treatment, to increase adherence to the treatment.